This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Current Status of Therapy

JAMA. 1970;214(13):2316-2321.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In 1960, the therapeutic indications for a mixture of an estrogen and a progestogen were extended to include contraception in the labeling approved by the Food and Drug Administration. Since then, the Council on Drugs has published various evaluations of individual oral contraceptive preparations and of these drugs as a group. In the Journal of The American Medical Association, Feb 27, 1967 (199:650-653), the Council on Drugs expressed the philosophy of the Council in the following statement from its Evaluation of Oral Contraceptives:

The development of the oral contraceptives, which readily control certain of the physiologic processes leading to conception, has broadened the meaning of the term therapeutics. For these pharmaceutic preparations are given to healthy people, and any possible hazards connected with their use, however remote, must be weighed against their expected benefits, perhaps more critically than has ever been the case before. This is often an uneasy . . . [Full Text PDF of this Article]

Footnotes
Reprint requests to Secretary, Council on Drugs, American Medical Association, 535 N Dearborn St, Chicago 60610.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?